Charles Schwab Investment Management Inc. lifted its position in shares of GoHealth, Inc. (NASDAQ:GOCO) by 3.4% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 197,737 shares of the company’s stock after buying an additional 6,520 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in GoHealth were worth $2,702,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Credit Suisse AG increased its holdings in shares of GoHealth by 51.0% during the 4th quarter. Credit Suisse AG now owns 4,528,846 shares of the company’s stock worth $61,864,000 after buying an additional 1,528,764 shares during the last quarter. BlackRock Inc. raised its holdings in shares of GoHealth by 3.5% in the 4th quarter. BlackRock Inc. now owns 3,503,594 shares of the company’s stock worth $47,860,000 after purchasing an additional 117,888 shares during the period. Alliancebernstein L.P. lifted its stake in shares of GoHealth by 5.0% in the 4th quarter. Alliancebernstein L.P. now owns 3,322,637 shares of the company’s stock valued at $45,387,000 after purchasing an additional 159,360 shares in the last quarter. Deerfield Management Company L.P. Series C purchased a new stake in shares of GoHealth during the 3rd quarter worth about $9,118,000. Finally, TCW Group Inc. increased its position in GoHealth by 85.1% during the 4th quarter. TCW Group Inc. now owns 620,767 shares of the company’s stock worth $8,480,000 after purchasing an additional 285,479 shares in the last quarter. Hedge funds and other institutional investors own 26.55% of the company’s stock.
In other GoHealth news, COO Shane E. Cruz sold 11,829 shares of the stock in a transaction that occurred on Wednesday, January 27th. The stock was sold at an average price of $15.02, for a total transaction of $177,671.58. Following the transaction, the chief operating officer now owns 75,000 shares of the company’s stock, valued at approximately $1,126,500. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Anita Pramoda bought 10,370 shares of the firm’s stock in a transaction dated Friday, March 12th. The stock was purchased at an average price of $9.99 per share, with a total value of $103,596.30. Following the transaction, the director now owns 22,275 shares in the company, valued at approximately $222,527.25. The disclosure for this purchase can be found here. In the last 90 days, insiders sold 200,000 shares of company stock valued at $2,975,500.
NASDAQ:GOCO opened at $12.03 on Wednesday. GoHealth, Inc. has a one year low of $9.82 and a one year high of $26.25. The business’s 50-day simple moving average is $11.70 and its 200 day simple moving average is $12.85.
GoHealth (NASDAQ:GOCO) last posted its quarterly earnings data on Monday, March 8th. The company reported $0.41 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.46 by ($0.05). The business had revenue of $445.90 million during the quarter, compared to the consensus estimate of $435.31 million. The company’s quarterly revenue was up 54.5% compared to the same quarter last year. As a group, equities research analysts predict that GoHealth, Inc. will post -0.28 earnings per share for the current year.
GoHealth, Inc operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareÂInternal; MedicareÂExternal; Individual and Family Plans (IFP) and OtherÂInternal; and Individual and Family Plans and OtherÂExternal.
Read More: What is Call Option Volume?
Want to see what other hedge funds are holding GOCO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GoHealth, Inc. (NASDAQ:GOCO).
Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.